The ZEST trial, a phase 3 study on MRD-guided therapy in breast cancer, was terminated early due to low randomization rates. ctDNA was most frequently detected within six months post-treatment, ...

More than a third (42.8%) of pediatric patients with hidradenitis suppurativa did not meet all major diagnostic criteria at the time of diagnosis, particularly due to failure to fulfill the recurrence ...

Implementing longer intervals between the completion of neoadjuvant therapy and surgery may have a positive effect on pathologic complete responses for patients with locally advanced rectal cancer.

CITCCA study data demonstrate strong association between ctDNA status and recurrence risk in stage I-III colorectal cancerMORRISVILLE, N.C.--(BUSINESS WIRE)--#ASCOGI--SAGA Diagnostics, a pioneer in ...